These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 27492436)

  • 1. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.
    Trejo P; Rauch F
    Osteoporos Int; 2016 Dec; 27(12):3427-3437. PubMed ID: 27492436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenesis imperfecta: diagnosis and treatment.
    Palomo T; Vilaça T; Lazaretti-Castro M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):381-388. PubMed ID: 28863000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.
    Sato A; Ouellet J; Muneta T; Glorieux FH; Rauch F
    Bone; 2016 May; 86():53-7. PubMed ID: 26927310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up in osteogenesis imperfecta type VI.
    Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
    Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oesteogenesis imperfecta--genetics, diagnosis and medical treatment].
    Brixen KT; Illum NO; Hansen B; Lund AM; Mosekilde L
    Ugeskr Laeger; 2007 Jan; 169(1):30-4. PubMed ID: 17217883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness to pamidronate treatment is not related to the genotype of type I collagen in patients with osteogenesis imperfecta.
    Kanno J; Saito-Hakoda A; Kure S; Fujiwara I
    J Bone Miner Metab; 2018 May; 36(3):344-351. PubMed ID: 28528406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic variability in patients with osteogenesis imperfecta caused by BMP1 mutations.
    Pollitt RC; Saraff V; Dalton A; Webb EA; Shaw NJ; Sobey GJ; Mughal MZ; Hobson E; Ali F; Bishop NJ; Arundel P; Högler W; Balasubramanian M
    Am J Med Genet A; 2016 Dec; 170(12):3150-3156. PubMed ID: 27576954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of scoliosis in young children with osteogenesis imperfecta undergoing intravenous bisphosphonate therapy.
    Kashii M; Kanayama S; Kitaoka T; Makino T; Kaito T; Iwasaki M; Kubota T; Yamamoto T; Ozono K; Yoshikawa H
    J Bone Miner Metab; 2019 May; 37(3):545-553. PubMed ID: 30187275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response.
    Zacharin M; Bateman J
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):163-74. PubMed ID: 11874181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diaphyseal Femur Fractures in Osteogenesis Imperfecta: Characteristics and Relationship With Bisphosphonate Treatment.
    Trejo P; Fassier F; Glorieux FH; Rauch F
    J Bone Miner Res; 2017 May; 32(5):1034-1039. PubMed ID: 28019684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous pamidronate in osteogenesis imperfecta type VII.
    Cheung MS; Glorieux FH; Rauch F
    Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, genetic characteristics and treatment outcomes of children and adolescents with osteogenesis imperfecta: a two-center experience.
    Erbaş İM; İlgün Gürel D; Manav Kabayeğit Z; Koç A; Ünüvar T; Abacı A; Böber E; Anık A
    Connect Tissue Res; 2022 Jul; 63(4):349-358. PubMed ID: 34107839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort.
    Hoyer-Kuhn H; Rehberg M; Netzer C; Schoenau E; Semler O
    Orphanet J Rare Dis; 2019 Sep; 14(1):219. PubMed ID: 31533771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum.
    Bardai G; Moffatt P; Glorieux FH; Rauch F
    Osteoporos Int; 2016 Dec; 27(12):3607-3613. PubMed ID: 27509835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.
    Song Y; Zhao D; Xu X; Lv F; Li L; Jiang Y; Wang O; Xia W; Xing X; Li M
    Osteoporos Int; 2018 Jun; 29(6):1389-1396. PubMed ID: 29520608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
    Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
    J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.
    Rauch F; Lalic L; Roughley P; Glorieux FH
    J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.